Diplomat Pharmacy (DPLO) Misses Q4 Revenues Below Estimates; Lowers FY19 Revenue Guidance Below Consensus, Offers FY19 EPS Guidance Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. ADYEN:NA
8. DVLT
9. ADYYF
10. WDAY

Go back to Diplomat Pharmacy (DPLO) Misses Q4 Revenues Below Estimates; Lowers FY19 Revenue Guidance Below Consensus, Offers FY19 EPS Guidance Below Consensus

Diplomat Pharmacy (DPLO) Appoints Daniel Davison as CFO

March 15, 2019 7:25 AM EDT

Diplomat Pharmacy, Inc. (NYSE: DPLO), announced today that the company's board of directors has appointed Dan Davison as chief financial officer and treasurer effective April 8, succeeding Atul Kavthekar.

Mr. Davison will report to Brian Griffin, Diplomat's chairman and CEO, and will lead the company's finance function, which is expected to be streamlined under Davison's direction. Mr. Kavthekar will remain with the company through a brief period to ensure a smooth transition of responsibilities.

"I want to thank Atul for his many contributions to... More